The New England Journal of Medicine

Original Article

Volume 345:3-8

July 5, 2001

Number 1

 

 

 

Risk of Uterine Rupture during Labor among Women with a Prior Cesarean Delivery

Mona Lydon-Rochelle, Ph.D., Victoria L. Holt, Ph.D., Thomas R. Easterling, M.D., and Diane P. Martin, Ph.D.

ABSTRACT

Background Each year in the United States, approximately 60 percent of women with a prior cesarean delivery who become pregnant again attempt labor. Concern persists that a trial of labor may increase the risk of uterine rupture, an uncommon but serious obstetrical complication.

Methods We conducted a population-based, retrospective cohort analysis using data from all primiparous women who gave birth to live singleton infants by cesarean section in civilian hospitals in Washington State from 1987 through 1996 and who delivered a second singleton child during the same period (a total of 20,095 women). We assessed the risk of uterine rupture for deliveries with spontaneous onset of labor, those with labor induced by prostaglandins, and those in which labor was induced by other means; these three groups of deliveries were compared with repeated cesarean delivery without labor.

Results Uterine rupture occurred at a rate of 1.6 per 1000 among women with repeated cesarean delivery without labor (11 women), 5.2 per 1000 among women with spontaneous onset of labor (56 women), 7.7 per 1000 among women whose labor was induced without prostaglandins (15 women), and 24.5 per 1000 among women with prostaglandin-induced labor (9 women). As compared with the risk in women with repeated cesarean delivery without labor, uterine rupture was more likely among women with spontaneous onset of labor (relative risk, 3.3; 95 percent confidence interval, 1.8 to 6.0), induction of labor without prostaglandins (relative risk, 4.9; 95 percent confidence interval, 2.4 to 9.7), and induction with prostaglandins (relative risk, 15.6; 95 percent confidence interval, 8.1 to 30.0).

Conclusions For women with one prior cesarean delivery, the risk of uterine rupture is higher among those whose labor is induced than among those with repeated cesarean delivery without labor. Labor induced with a prostaglandin confers the highest risk.


Each year in the United States, approximately 60 percent of women with a prior cesarean delivery have a trial of labor in a subsequent pregnancy. Concern persists that a trial of labor may increase the risk of maternal complications as compared with elective cesarean delivery. Such complications include uterine rupture, which is uncommon but serious and may result in hysterectomy, urologic injury, a need for blood transfusion, maternal death, and perinatal complications, including neurologic impairment and death.1,2,3,4

Population-based studies of the relation between a trial of labor and uterine rupture have had methodologic limitations and have produced inconsistent findings. A study in Nova Scotia, Canada, reported that a trial of labor was not significantly associated with uterine rupture; however, in that study, too few women had uterine rupture to provide meaningful results.2 In contrast, studies in Switzerland and California demonstrated a significantly higher risk of uterine rupture among women undergoing a trial of labor than among women with elective repeated cesarean delivery.1,5 However, these studies did not control for parity or the number of prior cesarean deliveries. In addition, although the rates of induction of labor among women with prior cesarean delivery have been increasing, none of these studies distinguished the risk of uterine rupture associated with a trial of labor with induction of labor from that without induction.6 We used statewide linked birth-certificate and hospital-discharge data to examine the risk of uterine rupture associated with spontaneous onset of labor, induction of labor not involving prostaglandins, induction of labor with prostaglandins, and repeated cesarean delivery without labor among women with one prior cesarean delivery.

Methods

Study Design

We conducted a population-based, retrospective cohort analysis using data obtained from the Washington State Birth Events Record Database. This data base links more than 95 percent of birth certificates in Washington State with maternal and infant records from the Comprehensive Hospital Discharge Reporting System for the hospitalization associated with delivery. The present cohort included all primiparous women who gave birth to live singleton infants by cesarean section in civilian hospitals in Washington from January 1, 1987, through December 31, 1996, and who delivered a second singleton child in Washington during the same period (a total of 20,525 women). Because a variable indicating that the women had a second cesarean section without labor ("repeat cesarean no labor") was not added to the birth certificates until 1989, we excluded the 430 women who had a second delivery before 1989. After the exclusion, 20,095 subjects remained for analysis. Demographic variables were derived from first and second birth certificates, information on payers from maternal and infant hospitalization-discharge data for the second delivery, and medical information from maternal and infant hospitalization-discharge data and birth certificates for both deliveries. The study was approved by the Human Subjects Review Committee at the University of Washington, Seattle, and the Human Research Review Board at the Washington State Department of Health, Olympia.

Definitions

Hospitals were classified as level III (providing tertiary care, with complete perinatal services), level II (with at least 500 births per year, with board-certified obstetricians and pediatricians on staff, and providing newborn intermediate care), or level I (having a licensed obstetrical unit, with fewer than 500 births per year or without one or more level II criteria).

A delivery was classified as a repeated cesarean delivery without labor if "repeat cesarean no labor" was checked on the birth certificate and if labor-related procedure or diagnosis codes of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)7 were not recorded on hospital-discharge forms. Labor was considered to have been induced if "induction of labor" was checked on the birth certificate or if any ICD-9-CM medical-induction procedure or diagnosis codes were recorded in hospital-discharge data. Induced labor was classified as induction of labor with prostaglandins if ICD-9-CM procedure code 96.49 was recorded on the hospital-discharge form. All other induced labor was classified as induction of labor without prostaglandins. According to these criteria, there were 6980 women who had repeated cesarean delivery without labor (34.7 percent), 1960 women who had induction of labor without prostaglandins (9.8 percent), 366 women who had induction of labor with prostaglandins (1.8 percent), and 10,789 women who had spontaneous onset of labor (53.7 percent) available for analysis. Uterine rupture was considered to have occurred if ICD-9-CM diagnosis code 665.0 or 665.1 was recorded on the hospital-discharge form.

Statistical Analysis

To assess the risk of uterine rupture associated with spontaneous onset of labor, induction of labor without prostaglandins, and induction of labor with prostaglandins, as compared with repeated cesarean delivery without labor, we used Mantel–Haenszel rate ratios to estimate the relative risks and 95 percent confidence intervals.8 Interactions between the mother's labor status at the second delivery and the type of uterine incision at the first delivery and the year of the second delivery were assessed by the likelihood-ratio test, with P values below 0.05 denoting statistical significance. No significant interactions were found. The following variables, reported at the time of the second delivery, were examined for possible confounding effects in all analyses: maternal age; race or ethnic background; marital status; smoking status during pregnancy; presence or absence of preexisting diabetes mellitus, chronic hypertension, moderate-to-severe preeclampsia, and genital herpes; interval between the deliveries; payer; hospital level; infant birth weight and estimated gestational age; presence or absence of breech presentation; and presence or absence of placenta previa. Variables were considered to be confounders if their inclusion changed the model's relative risk for uterine rupture at the second delivery associated with any labor-status category by 10 percent or more. With this criterion, no variables were considered to confound the models.

Because misoprostol was introduced into obstetrical practice for induction of labor in Washington in 1996 and has been linked to a higher risk of uterine rupture, we compared the risk of uterine rupture associated with prostaglandin-induced labor with that associated with repeated cesarean delivery without labor, with stratification according to birth year (before 1996 or during 1996). Because prostaglandin induction may be used differently according to whether there are chronic or perinatal health conditions — which may, in turn, be independently associated with uterine rupture — we performed a secondary analysis limited to the 18,419 women without diabetes mellitus, chronic hypertension, moderate-to-severe preeclampsia, breech presentation, genital herpes, or placenta previa (91.7 percent). Because a prior vertical uterine cesarean incision may also affect a woman's risk of uterine rupture, we conducted an analysis limited to the 19,822 women (98.6 percent) without a vertical cesarean uterine incision at the first delivery. Finally, since the severity of uterine rupture cannot be determined from diagnostic codes, we examined the frequency of the diagnosis of selected postpartum complications among women with and without uterine rupture. Differences between the two groups were compared with use of the Mantel–Haenszel chi-square test. Because the frequency of postpartum complications was low, it was not possible to evaluate the relation between labor status and specific complications of uterine rupture.

Results

Demographic and perinatal characteristics at the time of the second delivery were similar among women with spontaneous onset of labor and women with no trial of labor (Table 1). Women who underwent induction without prostaglandins were more likely than women who did not have a trial of labor to deliver infants whose estimated gestational age was more than 42 weeks. Women who underwent prostaglandin induction were less likely to deliver within two years of their first delivery and more likely to deliver at a level II hospital than women who had no trial of labor. The frequency of medical conditions and complications of pregnancy varied substantially among the groups (Table 2). Women who had spontaneous onset of labor were significantly less likely than women with no trial of labor to have diabetes mellitus, chronic hypertension, preeclampsia, a breech presentation, genital herpes, or placenta previa. Women with induction without prostaglandins were significantly less likely than women who did not undergo labor to have breech presentation, genital herpes, or placenta previa. Finally, women with prostaglandin induction were significantly less likely to have breech presentation or genital herpes than women who did not undergo labor.


View this table:
[in this window]
[in a new window]
 

Table 1. Characteristics of Second Deliveries among Women with a Prior Cesarean Delivery, Washington State, 1987 through 1996.

 

View this table:
[in this window]
[in a new window]
 

Table 2. Medical Conditions and Selected Complications of Pregnancy at the Time of the Second Delivery among Women with a Prior Cesarean Delivery.

 
In our study cohort, uterine rupture complicated 4.5 second singleton deliveries per 1000 (91 women). Uterine rupture occurred at a rate of 1.6 per 1000 among women with repeated cesarean delivery without labor (11 women), 5.2 per 1000 among women with spontaneous onset of labor (56 women), 7.7 per 1000 among women whose labor was induced without prostaglandins (15 women), and 24.5 per 1000 among women with prostaglandin-induced labor (9 women). Women with spontaneous onset of labor were more likely than women who did not undergo labor to have uterine rupture (relative risk, 3.3; 95 percent confidence interval, 1.8 to 6.0) (Table 3). A greater relative risk was observed among women with induced labor without prostaglandins (relative risk, 4.9; 95 percent confidence interval, 2.4 to 9.7), and particularly those with labor induced by prostaglandins (relative risk, 15.6; 95 percent confidence interval, 8.1 to 30.0). For women giving birth before misoprostol became generally available in 1996, the relative risk of uterine rupture associated with prostaglandin-induced labor was 14.1 (95 percent confidence interval, 6.1 to 33.0). The risk was similar among women who gave birth in 1996 (relative risk, 12.2; 95 percent confidence interval, 3.4 to 39.6). The risk estimates for uterine rupture associated with spontaneous or induced labor were not materially changed when we excluded women with diabetes mellitus, chronic hypertension, preeclampsia, breech presentation, genital herpes, or placenta previa (data not shown). There were no uterine ruptures among the 272 women with previous vertical incisions, and the results were unchanged when data on these women were excluded (data not shown). Women with uterine rupture were significantly more likely than women without uterine rupture to have postpartum complications (Table 4).


View this table:
[in this window]
[in a new window]
 

Table 3. Incidence and Relative Risk of Uterine Rupture during a Second Delivery among Women with a Prior Cesarean Delivery.

 

View this table:
[in this window]
[in a new window]
 

Table 4. Postpartum Complications of Second Deliveries among Women with a Prior Cesarean Delivery.

 
Discussion

In this longitudinal cohort study of 20,095 women whose first delivery of a singleton child was by cesarean delivery, a trial of labor at the second delivery was associated with a significant increase in the risk of uterine rupture. The risk of rupture was increased by a factor of approximately three in women with spontaneous labor; however, the rate of uterine rupture among these women was still quite low. The risk of uterine rupture was highest among women whose labor was induced, particularly when it was induced by prostaglandins.

Our findings are consistent with the results of two cross-sectional studies, which demonstrated increased risks of uterine rupture with a trial of labor in women with prior cesarean section.1,5 A countrywide study in Switzerland, which included 92 uterine ruptures, observed a doubling of the risk among women with a trial of labor, as compared with those who underwent elective repeated cesarean delivery.1 Similar risks were found in a California cohort analysis that used 1995 statewide hospital-discharge data, in which 393 uterine ruptures were reported.5 One longitudinal cohort study in Nova Scotia estimated that the relative risk of uterine rupture associated with a trial of labor, as compared with elective repeated cesarean delivery, was 5.2, but only 11 women had uterine rupture, and this increase in risk was not significant.2 None of those studies examined the effect of induction of labor on the risk of uterine rupture associated with a trial of labor. Three prior case series reported an increase in uterine rupture among women with prior cesarean delivery in whose second deliveries labor was induced by prostaglandins.9,10,11 However, these studies did not include a comparison group of women whose second deliveries were by cesarean section without labor.

In prior studies, information about a trial of labor was based on physician-survey or hospital-discharge data alone, and labor status may have been misclassified. Information in the present study came from linked birth-certificate and hospital-discharge data — an approach that increases the accuracy and completeness of data on obstetrical diagnoses and procedures.12 The use of longitudinally linked maternal data sets also allowed us to use an entire state's cohort of women with one prior cesarean delivery who had a second singleton delivery during a 10-year period; this method ensured that the number of subjects was adequate for the examination of a rare outcome. Since all levels of hospitals statewide were included, our findings represent a wide range of hospital settings.

Data derived from vital statistics and administrative records may be limited in completeness and in the accuracy of coding of obstetrical data. However, previous research has shown that 99.8 percent of cesarean deliveries are correctly classified when Washington State linked birth-certificate and hospital-discharge files are used.12 Inaccuracy in the measurement of exposure is possible, however; a previous study found that only 72 percent of women with induction of labor were correctly classified in the Washington State Birth Events Record Database, and no studies have reported on the accuracy of classification of the other exposure groups.12 Nonetheless, because the recording of labor status is unlikely to depend on uterine-rupture status, any misclassification would be random and would thus lead to underestimation of the risk associated with labor. Although we could not document the accuracy of coding for uterine rupture, the observed rate of uterine rupture of 4.5 per 1000 among women with prior cesarean delivery was consistent with the results of other studies (range, 3.2 per 1000 to 6.4 per 1000).1,3,5 Furthermore, the increased frequency of adverse postpartum complications among women with a diagnosis of uterine rupture suggests that this diagnosis code was clinically meaningful.

We did not have information on specific types and dosages of prostaglandin used, and therefore we could not evaluate the effects of different preparations. Although the American College of Obstetricians and Gynecologists currently advises against the use of misoprostol in women with prior uterine surgery, because of the reported increased frequency of uterine rupture, this prostaglandin analogue may have been used during 1996, the last year of our study period.11,13 However, the observation that the risk of rupture associated with prostaglandin-induced labor was increased in the years before misoprostol was available indicates that this preparation alone could not have been responsible for the increased risk seen with prostaglandin use.

An increased risk of uterine rupture may be attributed to factors other than labor status at a second delivery among women with prior cesarean delivery, and these factors may also influence the decision to undertake a trial of labor. We restricted our analysis to second singleton births, eliminating the potentially confounding effects of parity, more than one cesarean delivery, and multiple gestation, all of which could have predisposed women both to a scheduled repeated cesarean delivery and to uterine rupture.14,15 The results were similar when we excluded data from women with preexisting medical conditions or complications of pregnancy that might be expected to influence the mode of delivery and when we excluded data from women with prior vertical incisions.

At present, the data suggest that induction of labor increases the risk of uterine rupture among women with one prior cesarean delivery and that labor induced with use of a prostaglandin confers a greater relative risk. The overall effect of induction of labor with prostaglandins on uterine rupture is still unclear and may vary according to the preparation used, the regimen, and the degree of cervical readiness for induction.

Supported in part by grants from the Agency for Healthcare Research and Quality (5 T32 HS00034) and from the National Institutes of Health–National Institute of Nursing Research (T32 NR07039).

We are indebted to Nancy Fugate-Woods, Ph.D., for assistance and comments and to William O'Brien for data linkage and management support.


Source Information

From the Center for Women's Health Research, Department of Family and Child Nursing, School of Nursing (M.L.-R.), the Department of Epidemiology, School of Public Health and Community Medicine (V.L.H.), the Department of Obstetrics and Gynecology, School of Medicine (T.R.E.), and the Department of Health Services, School of Public Health and Community Medicine (M.L.-R., D.P.M.), University of Washington, Seattle.

Address reprint requests to Dr. Lydon-Rochelle at the Center for Women's Health Research, Mailstop 357262, University of Washington, Seattle, WA 98195-7262, or at [log in to unmask].

References

  1. Rageth JC, Juzi C, Grossenbacher H. Delivery after previous cesarean: a risk evaluation. Obstet Gynecol 1999;93:332-337.[Medline]
  1. McMahon MJ, Luther ER, Bowes WA Jr, Olshan AF. Comparison of a trial of labor with an elective second cesarean section. N Engl J Med 1996;335:689-695.[Abstract/Full Text]
  1. Leung AS, Leung EK, Paul RH. Uterine rupture after previous cesarean delivery: maternal and fetal consequences. Am J Obstet Gynecol 1993;169:945-950.[Medline]
  1. Stalnaker BL, Maher JE, Kleinman GE, Macksey JM, Fishman LA, Bernard JM. Characteristics of successful claims for payment by the Florida Neurologic Injury Compensation Association Fund. Am J Obstet Gynecol 1997;177:268-271.[Medline]
  1. Gregory KD, Korst LM, Cane P, Platt LD, Kahn K. Vaginal birth after cesarean and uterine rupture rates in California. Obstet Gynecol 1999;94:985-989.[Medline]
  1. Ventura SJ, Martin JA, Curtin SC, Matthews TJ, Park MM. Births: final data for 1998. National vital statistics reports. Vol. 48. No. 3. Hyattsville, Md.: National Center for Health Statistics, 2000:13. (DHHS publication no. (PHS) 2000-1120.)
  1. 1999 Hospital & payor international classification of diseases, 9th rev., clinical modification: ICD-9-CM. 5th ed. Vol. 1-3. Salt Lake City: Medicode, 1998.
  1. SAS/STAT users' guide: version 6. Cary, N.C.: SAS Institute, 1990.
  1. Raskin KS, Dachauer JD, Doeden AL, Rayburn WF. Uterine rupture after use of a prostaglandin E2 vaginal insert during vaginal birth after cesarean: a report of two cases. J Reprod Med 1999;44:571-574.[Medline]
  1. Plaut MM, Schwartz ML, Lubarsky SL. Uterine rupture associated with the use of misoprostol in the gravid patient with a previous cesarean section. Am J Obstet Gynecol 1999;180:1535-1542.[Medline]
  1. Wing DA, Lovett K, Paul RH. Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstet Gynecol 1998;91:828-830.[Medline]
  1. Parrish KM, Holt VL, Connell FA, Williams B, LoGerfo JP. Variations in the accuracy of obstetric procedures and diagnoses on birth records in Washington State, 1989. Am J Epidemiol 1993;138:119-127.[Abstract]
  1. Induction of labor with misoprostol. ACOG committee opinion no. 228. Washington, D.C.: American College of Obstetricians and Gynecologists, November 1999:1-2.
  1. Caughey AB, Shipp TD, Repke JT, Zelop CM, Cohen A, Lieberman E. Rate of uterine rupture during a trial of labor in women with one or two prior cesarean deliveries. Am J Obstet Gynecol 1999;181:872-876.[Medline]
  1. Flamm BL, Goings JR, Liu Y, Wolde-Tsadik G. Elective repeat cesarean delivery versus trial of labor: a prospective multicenter study. Obstet Gynecol 1994;83:927-932.[Medline]


Vaginal Delivery after Cesarean Section — Is the Risk Acceptable?

 Nearly 40 years ago, Douglas et al. documented the risk of uterine rupture during a trial of labor after cesarean section.1 Among more than 2000 women with scars from prior cesarean sections, uterine rupture occurred during labor in just over 1 percent, and more than a third of the fetuses in those cases died. The authors concluded, "Probably the most vehement objections to the policy of vaginal delivery after cesarean section allude to the occurrence of catastrophic ruptures of the uterine scar." That experience, coupled with the mantra "Once a cesarean, always a cesarean," cast the practice of vaginal delivery after cesarean section into widespread disrepute for decades.

Subsequently, the U.S. national cesarean-section rate rose dramatically, peaking in the late 1980s at nearly 23 percent. This increase attracted considerable attention, since cesarean sections generally result in greater short-term and long-term maternal morbidity, maternal mortality, and expense than vaginal deliveries. A third of the cesarean sections were elective repeated procedures, with absolute numbers rising as the rate of primary cesarean section rose.

An obvious way to curb the rising cesarean-section rate was to revive the practice of vaginal delivery after cesarean section. Enthusiastic reports of success2,3 and an optimistic meta-analysis that found no increase in perinatal mortality with a trial of labor4 propelled the juggernaut. Insurers initiated programs to promote vaginal delivery after cesarean section and to educate doctors and patients regarding its benefits. Some insurers even felt justified in refusing to pay for repeated cesarean sections that were not preceded by attempts at vaginal delivery. Individual physicians, and to some extent their professional organizations, were cajoled or coerced into supporting these programs, lest they be dropped from the roster of providers or portrayed as uncooperative and nonprogressive. As experience again accumulated, however, so too did reports of maternal and perinatal morbidity and mortality associated with vaginal delivery after cesarean section; most of these adverse effects were attributable to uterine rupture.5,6 Efforts to improve the safety of vaginal delivery after cesarean section have focused on attempts to identify risk factors for uterine rupture. Recent investigations into the effects of oxytocic agents have yielded inconsistent results without a clear message.7,8,9

In this issue of the Journal, Lydon-Rochelle et al. report on a study in which they used a large statewide data base of more than 20,000 women in Washington State to examine the risk of uterine rupture associated with various modes of delivery and induction of labor.10 All the women had undergone one previous cesarean section and were delivering a second singleton baby. The overall risk of uterine rupture was 4.5 per 1000, which is consistent with rates in other studies.7,8,9 The rate of uterine rupture associated with spontaneous onset of labor was 5.2 per 1000 and that associated with induction of labor without prostaglandins was 7.7 per 1000. These rates were significantly higher than the 1.6 per 1000 among women who had repeated cesarean sections without labor, but not significantly different from one another. Most striking was the rate of uterine rupture, 24.5 per 1000, when labor was induced with a prostaglandin.

Previous reports of two small, uncontrolled case series11,12 suggested that a 5 to 10 percent risk of uterine rupture was associated with use of misoprostol, a highly potent synthetic prostaglandin E1 analogue, to induce labor. The American College of Obstetricians and Gynecologists subsequently warned against the use of misoprostol for this purpose.13 Although Lydon-Rochelle et al. did not have information about the prostaglandin preparations used to induce labor in the women in their cohort, they performed an analysis with stratification according to year to look specifically at deliveries before and after 1996, when misoprostol began to be widely used. They found that the risk associated with the use of a prostaglandin to induce labor was similar during the two periods, suggesting that the risk is not limited to misoprostol but extends to other prostaglandin preparations as well.

The 91 women in the study by Lydon-Rochelle et al. who had uterine ruptures had substantially greater rates of several postpartum complications, suggesting that these ruptures were clinically important and not merely instances of asymptomatic dehiscence. Notably, the incidence of infant death was 10 times as high among the 91 women who had uterine rupture as among the 20,004 who did not (5.5 percent vs. 0.5 percent). It is important to emphasize that this study, like all others to date, was an observational study of the results of clinical practice and not a randomized trial.

The relative risk of 3.3 in the present study for uterine rupture in women with a spontaneous onset of labor, as compared with those who underwent elective repeated cesarean section, is consistent with the odds ratio of 2.1 for a similar comparison reported in a recent meta-analysis of 11 studies involving a total of 39,000 subjects.14 This meta-analysis also found significant increases in the risks of fetal death (odds ratio, 1.7) and of an Apgar score of less than 7 at five minutes (odds ratio, 2.2) associated with a trial of labor as compared with elective repeated cesarean delivery. These risk estimates reflect broad experience in a wide range of clinical-practice settings. There is no reason to believe that improvements in clinical care can substantially reduce the risks of uterine rupture and perinatal mortality.

Given the potential risks, why might a woman choose a trial of labor? Women who successfully deliver vaginally generally have less postpartum discomfort, shorter hospital stays, and shorter periods of disability than women who undergo repeated cesarean section. A trial of labor may be associated with a lower risk of fever than elective repeated cesarean section.14 Women who plan future pregnancies may prefer to avoid repeated cesarean deliveries that further increase the risks of uterine rupture, placenta accreta, and morbidity related to multiple abdominal surgeries. Finally, there may be social and cultural reasons why some women prefer vaginal delivery.

Slovic recognized that "experts" (such as health care policy analysts, public health officials, and insurance company executives) perceive risk differently from laypeople (patients).15 Experts judge risk according to technical estimates of numbers of deaths. The rate of perinatal death, for example, is 5.8 per 1000 with trials of labor after cesarean section, as compared with 3.4 per 1000 with elective repeated cesarean section.14 The absolute difference between them is 2.4 per 1000 (or 1 per 417), a relatively small number. Patients are more apt to judge risk according to the degree to which they "dread" the unwanted outcome. "Dread," in turn, is determined by the degree to which the outcome is irreversible, potentially lethal, and uncontrollable. By these criteria, the possibility of perinatal death resulting from a trial of labor would probably be associated with a high degree of dread.

The process of obtaining informed consent for medical care requires that physicians provide patients with the information that a reasonable person would want under the circumstances. Most reasonable women considering a trial of labor after a prior cesarean delivery would want to know that spontaneous labor is associated with a tripling of the risk of uterine rupture and that induction of labor with prostaglandins is associated with an increase in that risk by a factor of 15. Should a rupture occur, the risk of perinatal mortality increases by a factor of 10. Some reasonable persons may conclude that these absolute risks are so small that they are worth taking and are outweighed by the benefits of a successful vaginal birth. Nonetheless, these issues must be discussed with each patient, and she must make that decision for herself. After a thorough discussion of the risks and benefits of attempting a vaginal delivery after cesarean section, a patient might ask, "But doctor, what is the safest thing for my baby?" Given the findings of Lydon-Rochelle et al., my unequivocal answer is: elective repeated cesarean section.


Michael F. Greene, M.D.
Massachusetts General Hospital
Boston, MA 02114

References

  1. Douglas RG, Birnbaum SJ, MacDonald FA. Pregnancy and labor following cesarean section. Am J Obstet Gynecol 1963;86:961-971.
  1. Martin JN Jr, Harris BA Jr, Huddleston JF, et al. Vaginal delivery following previous cesarean birth. Am J Obstet Gynecol 1983;146:255-263.[Medline]
  1. Phelan JP, Clark SL, Diaz F, Paul RH. Vaginal birth after cesarean. Am J Obstet Gynecol 1987;157:1510-1515.[Medline]
  1. Rosen MG, Dickinson JC, Westhoff CL. Vaginal birth after cesarean: a meta-analysis of morbidity and mortality. Obstet Gynecol 1991;77:465-470.[Medline]
  1. Scott JR. Mandatory trial of labor after cesarean delivery: an alternative viewpoint. Obstet Gynecol 1991;77:811-814.[Medline]
  1. Farmer RM, Kirschbaum T, Potter D, Strong TH, Medearis AL. Uterine rupture during trial of labor after previous cesarean section. Am J Obstet Gynecol 1991;165:996-1001.[Medline]
  1. Ravasia DJ, Wood SL, Pollard JK. Uterine rupture during induced trial of labor among women with previous cesarean delivery. Am J Obstet Gynecol 2000;183:1176-1179.[Medline]
  1. Zelop CM, Shipp TD, Repke JT, Cohen A, Caughey AB, Lieberman E. Uterine rupture during induced or augmented labor in gravid women with one prior cesarean delivery. Am J Obstet Gynecol 1999;181:882-886.[Medline]
  1. Rageth JC, Juzi C, Grossenbacher H. Delivery after previous cesarean: a risk evaluation. Obstet Gynecol 1999;93:332-337.[Medline]
  1. Lydon-Rochelle M, Holt VL, Easterling TR, Martin DP. Risk of uterine rupture during labor among women with a prior cesarean delivery. N Engl J Med 2001;345:3-8.[Abstract/Full Text]
  1. Wing DA, Lovett K, Paul RH. Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstet Gynecol 1998;91:828-830.[Medline]
  1. Plaut MM, Schwartz ML, Lubarsky SL. Uterine rupture associated with the use of misoprostol in the gravid patient with a previous cesarean section. Am J Obstet Gynecol 1999;180:1535-1542.[Medline]
  1. Induction of labor with misoprostol: ACOG committee opinion. Washington, D.C.: American College of Obstetricians and Gynecologists, 1999.
  1. Mozurkewich EL, Hutton EK. Elective repeat cesarean delivery versus trial of labor: a meta-analysis of the literature from 1989 to 1999. Am J Obstet Gynecol 2000;183:1187-1197.[Medline]
  1. Slovic P. Perception of risk. Science 1987;236:280-285.[Medline]


 

Edward E. Rylander, M.D.

Diplomat American Board of Family Practice.

Diplomat American Board of Palliative Medicine.